Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open-label phase 3 study.
| Image |  |
|---|---|
| Description | scientific article published on 13 March 2018 |
| Author/s |
author: Xiao-Jun Huang Yu Hu |
| Publication date | March 13, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |